Author
Listed:
- Meng Jiang
(Dana-Farber Cancer Institute, Harvard Medical School
Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University)
- Yue Kang
(Dana-Farber Cancer Institute, Harvard Medical School
Chinese Academy of Sciences)
- Tomasz Sewastianik
(Dana-Farber Cancer Institute, Harvard Medical School
Institute of Hematology and Transfusion Medicine)
- Jiao Wang
(Dana-Farber Cancer Institute, Harvard Medical School
Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University)
- Helen Tanton
(Dana-Farber Cancer Institute, Harvard Medical School)
- Keith Alder
(Dana-Farber Cancer Institute, Harvard Medical School)
- Peter Dennis
(Dana-Farber Cancer Institute, Harvard Medical School)
- Yu Xin
(Dana-Farber Cancer Institute, Harvard Medical School)
- Zhongqiu Wang
(Dana-Farber Cancer Institute, Harvard Medical School
Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer)
- Ruiyang Liu
(Dana-Farber Cancer Institute, Harvard Medical School)
- Mengyun Zhang
(Dana-Farber Cancer Institute, Harvard Medical School)
- Ying Huang
(Dana-Farber Cancer Institute, Harvard Medical School)
- Massimo Loda
(Dana-Farber Cancer Institute, Harvard Medical School)
- Amitabh Srivastava
(Brigham and Women’s Hospital, Harvard Medical School)
- Runsheng Chen
(Chinese Academy of Sciences)
- Ming Liu
(Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University)
- Ruben D. Carrasco
(Dana-Farber Cancer Institute, Harvard Medical School
Brigham and Women’s Hospital, Harvard Medical School)
Abstract
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, which despite recent advances in treatment, remains incurable due to molecular heterogeneity of tumor cells. The B-cell lymphoma 9 (BCL9) oncogene functions as a transcriptional co-activator of the Wnt/β-catenin pathway, which plays critical roles in CRC pathogenesis. Here we have identified a β-catenin-independent function of BCL9 in a poor-prognosis subtype of CRC tumors characterized by expression of stromal and neural associated genes. In response to spontaneous calcium transients or cellular stress, BCL9 is recruited adjacent to the interchromosomal regions, where it stabilizes the mRNA of calcium signaling and neural associated genes by interacting with paraspeckle proteins. BCL9 subsequently promotes tumor progression and remodeling of the tumor microenvironment (TME) by sustaining the calcium transients and neurotransmitter-dependent communication among CRC cells. These data provide additional insights into the role of BCL9 in tumor pathogenesis and point towards additional avenues for therapeutic intervention.
Suggested Citation
Meng Jiang & Yue Kang & Tomasz Sewastianik & Jiao Wang & Helen Tanton & Keith Alder & Peter Dennis & Yu Xin & Zhongqiu Wang & Ruiyang Liu & Mengyun Zhang & Ying Huang & Massimo Loda & Amitabh Srivasta, 2020.
"BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins,"
Nature Communications, Nature, vol. 11(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13842-7
DOI: 10.1038/s41467-019-13842-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13842-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.